Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion
- 12 January 2004
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (5) , 549-552
Abstract
We retrospectively compared the incidence of acute graft-versus-host disease (GVHD) before and after September 1999, when we changed the mode of cyclosporine A (CsA) administration from twice-daily infusions (TD) (n=58) to continuous infusion (CIF) (n=71). The incidence of grade II–IV acute GVHD in the CIF group (56%) was significantly higher than that in the TD group (27%, P=0.00022). Multivariate analysis identified only two independent significant risk factors for the development of grade II–IV acute GVHD; CIF of CsA (relative risk 2.59, 95% CI 1.46–4.60, P=0.0011) and the presence of HLA mismatch (2.01, 95% CI 1.15–3.53, P=0.014). The incidence of relapse was significantly lower in the CIF group when adjusted for disease status before transplantation (0.41, 95% CI 0.18–0.95, P=0.038), which resulted in better disease-free survival in high-risk patients (43 vs 16% at 2 years, P=0.039), but not in standard-risk patients (72 vs 80%, P=0.45). CIF of CsA with a target level of 250–400 ng/ml may not be appropriate for GVHD prophylaxis in standard-risk patients.Keywords
This publication has 6 references indexed in Scilit:
- Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in JapanBone Marrow Transplantation, 2001
- Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsStatistics in Medicine, 1999
- A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT)Bone Marrow Transplantation, 1997
- Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantationAnnals of Hematology, 1994
- Comparison of a Monoclonal Antibody Fluorescent Polarization Immunoassay with Monoclonal Antibody Radioimmunoassay for Cyclosporin Determination in Whole BloodTherapeutic Drug Monitoring, 1992
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975